SEC Company Response from Twist Bioscience Corp (TWST) (CIK 0001581280) (TWST) — May 6, 2019
Twist Bioscience Corp (TWST) (CIK 0001581280)
Date: May 6, 2019 · CIK: 0001581280 · Accession: 0001193125-19-138473
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-231239
Letter
Re: Twist Bioscience Corporation Acceleration Request
May 6, 2019
VIA EDGAR
U.S. Securities and Exchange Commission
F Street, N.E.
Washington, D.C. 20549
Attn: Donald Field
Acceleration Request
Requested Date:
May 8, 2019
Requested Time:
4:30 p.m. Eastern Time
Ladies and Gentlemen:
Twist Bioscience Corporation (the “Company”) hereby requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to declare the Company’s Registration Statement on Form S-1 (File No. 333-231239), as amended, effective at the “Requested Date” and “Requested Time” set forth above or as soon thereafter as practicable.
The Company hereby authorizes Andrew D. Thorpe or Melissa V. Frayer, both of whom are attorneys with the Company’s outside legal counsel, Orrick, Herrington & Sutcliffe LLP, to orally modify or withdraw this request for acceleration.
The Company requests that it be notified of such effectiveness by a telephone call to Mr. Thorpe at (415) 773-5970, or in his absence, Ms. Frayer at (415) 773-5402.
[Signature page follows]
Sincerely,
TWIST BIOSCIENCE CORPORATION
Show Raw Text
CORRESP 1 filename1.htm CORRESP May 6, 2019 VIA EDGAR U.S. Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Attn: Donald Field Re: Twist Bioscience Corporation Acceleration Request Acceleration Request Requested Date: May 8, 2019 Requested Time: 4:30 p.m. Eastern Time Ladies and Gentlemen: Twist Bioscience Corporation (the “Company”) hereby requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to declare the Company’s Registration Statement on Form S-1 (File No. 333-231239), as amended, effective at the “Requested Date” and “Requested Time” set forth above or as soon thereafter as practicable. The Company hereby authorizes Andrew D. Thorpe or Melissa V. Frayer, both of whom are attorneys with the Company’s outside legal counsel, Orrick, Herrington & Sutcliffe LLP, to orally modify or withdraw this request for acceleration. The Company requests that it be notified of such effectiveness by a telephone call to Mr. Thorpe at (415) 773-5970, or in his absence, Ms. Frayer at (415) 773-5402. [Signature page follows] Sincerely, TWIST BIOSCIENCE CORPORATION By: /s/ Mark Daniels Name: Mark Daniels Title: Chief Legal Officer, Secretary and Chief Ethics and Compliance Officer cc: Emily Leproust, Twist Bioscience Corporation Andrew D. Thorpe, Orrick, Herrington & Sutcliffe, LLP Melissa V. Frayer, Orrick, Herrington & Sutcliffe, LLP Brian J. Cuneo, Latham & Watkins LLP